Rosuvastatin Calcium Market Regional Analysis, Demand Analysis and Competitive Outlook 2025-2032
The global Rosuvastatin Calcium market is experiencing steady growth, driven by rising cardiovascular disease (CVD) prevalence, increasing statin prescriptions, and expansion of generic drug manufacturing. Valued at USD 519 million in 2024, the market is projected to reach USD 693 million by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3%. This growth reflects the critical role of rosuvastatin calcium in managing cholesterol levels and reducing cardiovascular risk worldwide.
